You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: March 20, 2025

Drug Price Trends for NDC 50102-0224


✉ Email this page to a colleague

« Back to Dashboard


Best Wholesale Price for NDC 50102-0224

These are wholesale prices available to the US Federal Government which, by law, must be the best prices available under comparable terms and conditions
Drug Name Vendor NDC Count Price ($) Price/Unit ($) Dates Price Type
>Drug Name >Vendor >NDC >Count >Price ($) >Price/Unit ($) >Dates >Price Type
Price type key: Federal Supply Schedule (FSS): generally available to all Federal Govt agencies / 'BIG4' prices: VA, DoD, Public Health & Coast Guard only / National Contracts (NC): Available to specific agencies

Market Analysis and Price Projections for the Pharmaceutical Industry: Implications for NDC 50102-0224

Introduction

The pharmaceutical industry is a complex and dynamic sector, influenced by a multitude of factors including regulatory requirements, market demand, and economic conditions. This article will delve into the market analysis and price projections for the pharmaceutical industry, with a focus on the implications for a specific National Drug Code (NDC), 50102-0224.

Understanding the National Drug Code (NDC)

The NDC is a unique, three-segment number assigned by the FDA to identify drugs in the United States. It is crucial for tracking drugs from the manufacturer to the point of sale, ensuring accurate reimbursement, and managing inventory and supply chain security[1][4].

Current Market Trends in Pharmaceutical Expenditures

In 2023, overall pharmaceutical expenditures in the U.S. saw a significant increase of 13.6% compared to 2022, reaching a total of $722.5 billion. This growth was driven by increased utilization (6.5%), new drugs (4.2%), and price increases (2.9%)[2].

Projection for 2024

For 2024, it is anticipated that overall prescription drug spending will rise by 10.0% to 12.0%, with clinics and hospitals expecting an increase of 11.0% to 13.0% and 0% to 2.0%, respectively. Specialty, endocrine, and cancer drugs are expected to continue driving these expenditures[2].

Over-The-Counter (OTC) Drugs Market

The U.S. OTC drugs market is also growing, driven by the high cost of prescription drugs and increased approvals of OTC drugs. The market size is estimated at $42.80 billion in 2024 and is projected to reach $53 billion by 2029, growing at a CAGR of 4.40% during the forecast period[3].

Price Transparency and Volatility

Price transparency remains a critical issue in the pharmaceutical industry. For instance, Oregon's Drug Price Transparency Program reported significant price increases for both generic and brand-name drugs in 2022. The median price increase for generic drugs was 19.9%, while for brand-name drugs it was 13.4%. Extreme cases, such as a 2,527% increase for a generic naproxen, highlight the volatility in drug pricing[5].

Factors Influencing Drug Prices

Several factors influence drug prices, including:

  • New Drug Approvals: New drugs entering the market can significantly impact spending, especially if they are high-cost treatments.
  • Patent Expirations: The expiration of patents can lead to the introduction of generics, which can reduce prices but may also affect the overall market dynamics.
  • Regulatory Policies: Changes in regulatory policies and legislation can impact drug pricing and availability.
  • Utilization and Demand: Increased utilization of drugs, particularly in clinics and hospitals, drives up expenditures[2].

Implications for NDC 50102-0224

While specific data for NDC 50102-0224 is not provided, the general trends and factors influencing the pharmaceutical market can be applied:

Regulatory Compliance

The drug associated with NDC 50102-0224 must comply with FDA regulations, including registration and listing requirements. This ensures that the drug is accurately tracked and identified within the supply chain[1][4].

Market Demand and Utilization

If the drug is widely used or sees an increase in utilization, it could contribute to higher expenditures in its respective category. For example, if it falls under the specialty or endocrine drug categories, it may be part of the drivers for increased spending in these areas[2].

Price Dynamics

The price of the drug could be influenced by the broader market trends, including price increases driven by new drug approvals, patent expirations, and regulatory changes. High-cost prescription drugs often see shifts towards OTC alternatives, which could impact pricing strategies[2][3].

Supply Chain and Inventory Management

The NDC ensures accurate tracking and inventory management, which is crucial for maintaining supply chain security. Automated systems in clinics, hospitals, and pharmacies rely on NDCs for ordering and restocking drugs[4].

Key Takeaways

  • Market Growth: Pharmaceutical expenditures are expected to rise significantly in 2024, driven by increased utilization, new drugs, and price increases.
  • Regulatory Compliance: Drugs must comply with FDA regulations, including the assignment of an NDC.
  • Price Volatility: Drug prices can be highly volatile, influenced by various market and regulatory factors.
  • Supply Chain Management: NDCs play a critical role in ensuring the accurate tracking and management of drugs within the supply chain.

FAQs

Q: What is the National Drug Code (NDC) and its significance? A: The NDC is a unique three-segment number assigned by the FDA to identify drugs in the U.S., crucial for tracking, reimbursement, and supply chain management.

Q: How are pharmaceutical expenditures projected to change in 2024? A: Overall prescription drug spending is expected to rise by 10.0% to 12.0%, with clinics and hospitals seeing an increase of 11.0% to 13.0% and 0% to 2.0%, respectively.

Q: What factors influence drug prices? A: New drug approvals, patent expirations, regulatory policies, and utilization demand are key factors influencing drug prices.

Q: How does the OTC drugs market impact the pharmaceutical industry? A: The OTC drugs market is growing due to the high cost of prescription drugs and increased approvals, which can shift market dynamics and pricing strategies.

Q: Why is price transparency important in the pharmaceutical industry? A: Price transparency helps in understanding and addressing significant price increases and volatility, ensuring accountability in drug pricing.

Sources

  1. FDA's National Drug Code Directory - FDA
  2. National trends in prescription drug expenditures and projections for 2024 - PubMed
  3. U.S. OTC Drugs Market Forecast Report 2024-2029 - GlobeNewswire
  4. National Drug Code (NDC) for Healthcare Providers - YouTube
  5. Prescription Drug Price Transparency Results and Recommendations - Oregon Department of Consumer and Business Services

More… ↓

⤷  Try for Free

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.